Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is Trail dependent

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2148-2154

  Gurung, Prajwal ^a   Rai, Deepa ^a   Condotta, Stephanie A ^a   Babcock, Jeffrey C ^b   Badovinac, Vladimir P ^a,b   Griffith, Thomas S ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; DEATH RECEPTOR 5; GLYCOPROTEIN P 15095; LISTERIOLYSIN O; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CECUM; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LIGATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUNCTURE; SECONDARY INFECTION; SEPSIS; WEIGHT REDUCTION;

ANIMALS; CELL SEPARATION; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNE TOLERANCE; LISTERIOSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SEPSIS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 80052677149     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101180     Document Type: Article

References (59)

1. Angus, D. C., C. A. Pereira, and E. Silva. 2006. Epidemiology of severe sepsis around the world. Endocr. Metab. Immune Disord. Drug Targets 6: 207-212. (Pubitemid 43881034)
2. Muenzer, J. T., C. G. Davis, K. Chang, R. E. Schmidt, W. M. Dunne, C. M. Coopersmith, and R. S. Hotchkiss. 2010. Characterization and modulation of the immunosuppressive phase of sepsis. Infect. Immun. 78: 1582-1592.
3. Rittirsch, D., M. A. Flierl, and P. A. Ward. 2008. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8: 776-787.
4. Heidecke, C. D., T. Hensler, H. Weighardt, N. Zantl, H. Wagner, J. R. Siewert, and B. Holzmann. 1999. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am. J. Surg. 178: 288-292.
5. Van Zoelen, M. A., P. F. Laterre, S. Q. Van Veen, J. W. Van Till, X. Wittebole, P. Bresser, M. W. Tanck, T. Dugernier, A. Ishizaka, M. A. Boermeester, and T. Van der Poll. 2007. Systemic and local high mobility group box 1 concentrations during severe infection. Crit. Care Med. 35: 2799-2804. (Pubitemid 350175778)
6. Emonts, M., F. C. Sweep, N. Grebenchtchikov, A. Geurts-Moespot, M. Knaup, A. L. Chanson, V. Erard, P. Renner, P. W. Hermans, J. A. Hazelzet, and T. Calandra. 2007. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin. Infect. Dis. 44: 1321-1328. (Pubitemid 46717294)
7. Van Zoelen, M. A., T. Vogl, D. Foell, S. Q. Van Veen, J. W. Van Till, S. Florquin, M. W. Tanck, X. Wittebole, P. F. Laterre, M. A. Boermeester, et al. 2009. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am. J. Respir. Crit. Care Med. 180: 1098-1106.
8. Klesney-Tait, J., I. R. Turnbull, and M. Colonna. 2006. The TREM receptor family and signal integration. Nat. Immunol. 7: 1266-1273. (Pubitemid 46111244)
9. Netea, M. G., T. Azam, G. Ferwerda, S. E. Girardin, S. H. Kim, and C. A. Dinarello. 2006. Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. J. Leukoc. Biol. 80: 1454-1461. (Pubitemid 44904984)
10. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664. (Pubitemid 18005583)
11. Lorente, J. A., and J. C. Marshall. 2005. Neutralization of tumor necrosis factor in preclinical models of sepsis. Shock 24(Suppl 1): 107-119.
12. Fischer, E., M. A. Marano, K. J. Van Zee, C. S. Rock, A. S. Hawes, W. A. Thompson, L. DeForge, J. S. Kenney, D. G. Remick, D. C. Bloedow, et al. 1992. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89: 1551-1557.
13. Ohlsson, K., P. Björk, M. Bergenfeldt, R. Hageman, and R. C. Thompson. 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348: 550-552. (Pubitemid 120015108)
14. Yang, Q. H., and C. Du. 2004. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J. Biol. Chem. 279: 16963-16970. (Pubitemid 38560449)
15. Deans, K. J., M. Haley, C. Natanson, P. Q. Eichacker, and P. C. Minneci. 2005. Novel therapies for sepsis: a review. J. Trauma 58: 867-874. (Pubitemid 40592766)
16. Nasraway, S. A. Jr. 1999. Sepsis research: we must change course. Crit. Care Med. 27: 427-430.
17. Hotchkiss, R. S., and S. Opal. 2010. Immunotherapy for sepsis - a new approach against an ancient foe. N. Engl. J. Med. 363: 87-89.
18. Hotchkiss, R. S., K. C. Chang, M. H. Grayson, K. W. Tinsley, B. S. Dunne, C. G. Davis, D. F. Osborne, and I. E. Karl. 2003. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl. Acad. Sci. USA 100: 6724-6729. (Pubitemid 36666647)
19. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, K. C. Chang, J. P. Cobb, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96: 14541-14546. (Pubitemid 30000686)
20. Hotchkiss, R. S., P. E. Swanson, C. M. Knudson, K. C. Chang, J. P. Cobb, D. F. Osborne, K. M. Zollner, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol. 162: 4148-4156. (Pubitemid 29314800)
21. Hotchkiss, R. S., K. W. McConnell, K. Bullok, C. G. Davis, K. C. Chang, S. J. Schwulst, J. C. Dunne, G. P. Dietz, M. Bähr, J. E. McDunn, et al. 2006. TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo. J. Immunol. 176: 5471-5477.
22. Hotchkiss, R. S., P. E. Swanson, B. D. Freeman, K. W. Tinsley, J. P. Cobb, G. M. Matuschak, T. G. Buchman, and I. E. Karl. 1999. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27: 1230-1251. (Pubitemid 29379358)
23. Unsinger, J., H. Kazama, J. S. McDonough, T. S. Griffith, R. S. Hotchkiss, and T. A. Ferguson. 2010. Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism. J. Immunol. 184: 6766-6772.
24. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823. (Pubitemid 39336297)
25. Harty, J. T., and V. P. Badovinac. 2008. Shaping and reshaping CD8+ T-cell memory. Nat. Rev. Immunol. 8: 107-119. (Pubitemid 351161304)
26. Badovinac, V. P., and J. T. Harty. 2007. Manipulating the rate of memory CD8+ T cell generation after acute infection. J. Immunol. 179: 53-63. (Pubitemid 46986517)
27. Brunt, L. M., D. A. Portnoy, and E. R. Unanue. 1990. Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J. Immunol. 145: 3540-3546.
28. Mielke, M. E., G. Niedobitek, H. Stein, and H. Hahn. 1989. Acquired resistance to Listeria monocytogenes is mediated by Lyt-2+ T cells independently of the influx of monocytes into granulomatous lesions. J. Exp. Med. 170: 589-594. (Pubitemid 19204285)
29. Ladel, C. H., I. E. Flesch, J. Arnoldi, and S. H. Kaufmann. 1994. Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection. J. Immunol. 153: 3116-3122. (Pubitemid 24292536)
30. Kaufmann, S. H., and C. H. Ladel. 1994. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. Immunobiology 191: 509-519. (Pubitemid 24331477)
31. Sacks, J. A., and M. J. Bevan. 2008. TRAIL deficiency does not rescue impaired CD8+ T cell memory generated in the absence of CD4+ T cell help. J. Immunol. 180: 4570-4576.
32. Sedger, L. M., M. B. Glaccum, J. C. Schuh, S. T. Kanaly, E. Williamson, N. Kayagaki, T. Yun, P. Smolak, T. Le, R. Goodwin, and B. Gliniak. 2002. Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. Eur. J. Immunol. 32: 2246-2254. (Pubitemid 34965887)
33. Finnberg, N., J. J. Gruber, P. Fei, D. Rudolph, A. Bric, S. H. Kim, T. F. Burns, H. Ajuha, R. Page, G. S. Wu, et al. 2005. DR5 knockout mice are compromised in radiation-induced apoptosis. Mol. Cell. Biol. 25: 2000-2013. (Pubitemid 40280162)
34. Rittirsch, D., M. S. Huber-Lang, M. A. Flierl, and P. A. Ward. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4: 31-36.
35. Wirth, T. C., J. T. Harty, and V. P. Badovinac. 2010. Modulating numbers and phenotype of CD8+ T cells in secondary immune responses. Eur. J. Immunol. 40: 1916-1926.
36. Oberholzer, A., C. Oberholzer, and L. L. Moldawer. 2001. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16: 83-96. (Pubitemid 33596740)
37. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150. (Pubitemid 36056721)
38. Rai, D., N. L. Pham, J. T. Harty, and V. P. Badovinac. 2009. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J. Immunol. 183: 7672-7681.
39. Corbin, G. A., and J. T. Harty. 2004. Duration of infection and antigen display have minimal influence on the kinetics of the CD4+ T cell response to Listeria monocytogenes infection. J. Immunol. 173: 5679-5687. (Pubitemid 39392156)
40. Geginat, G., S. Schenk, M. Skoberne, W. Goebel, and H. Hof. 2001. A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J. Immunol. 166: 1877-1884. (Pubitemid 32114674)
41. Tasew, G., S. Nylén, T. Lieke, B. Lemu, H. Meless, N. Ruffin, D. Wolday, A. Asseffa, H. Yagita, S. Britton, et al. 2010. Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration. PLoS Negl. Trop. Dis. 4: e844.
42. Seki, N., Y. Hayakawa, A. D. Brooks, J. Wine, R. H. Wiltrout, H. Yagita, J. E. Tanner, M. J. Smyth, and T. J. Sayers. 2003. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer. Cancer Res. 63: 207-213. (Pubitemid 36070441)
43. Fang, Y., G. C. Sharp, H. Yagita, and H. Braley-Mullen. 2008. A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis. J. Pathol. 216: 505-513.
44. Unsinger, J., H. Kazama, J. S. McDonough, R. S. Hotchkiss, and T. A. Ferguson. 2009. Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury. J. Leukoc. Biol. 85: 382-390.
45. Muenzer, J. T., C. G. Davis, B. S. Dunne, J. Unsinger, W. M. Dunne, and R. S. Hotchkiss. 2006. Pneumonia after cecal ligation and puncture: a clinically relevant "two-hit" model of sepsis. Shock 26: 565-570. (Pubitemid 44789629)
46. Delano, M. J., T. Thayer, S. Gabrilovich, K. M. Kelly-Scumpia, R. D. Winfield, P. O. Scumpia, A. G. Cuenca, E. Warner, S. M. Wallet, M. A. Wallet, et al. 2011. Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J. Immunol. 186: 195-202.
47. Porter, B. B., and J. T. Harty. 2006. The onset of CD8+-T-cell contraction is influenced by the peak of Listeria monocytogenes infection and antigen display. Infect. Immun. 74: 1528-1536. (Pubitemid 43346785)
48. Darji, A., D. Bruder, S. zur Lage, B. Gerstel, T. Chakraborty, J. Wehland, and S. Weiss. 1998. The role of the bacterial membrane protein ActA in immunity and protection against Listeria monocytogenes. J. Immunol. 161: 2414-2420. (Pubitemid 28397056)
49. Gao, Y., J. M. Herndon, H. Zhang, T. S. Griffith, and T. A. Ferguson. 1998. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188: 887-896. (Pubitemid 28433415)
50. +) T cells produce active immune unresponsiveness. J. Immunol. 168: 5589-5595.
51. Griffith, T. S., H. Kazama, R. L. VanOosten, J. K. Earle, Jr., J. M. Herndon, D. R. Green, and T. A. Ferguson. 2007. Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J. Immunol. 178: 2679-2687. (Pubitemid 46333144)
52. Griffith, T. S., E. L. Brincks, P. Gurung, T. A. Kucaba, and T. A. Ferguson. 2011. Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells. J. Immunol. 186: 791v798.
53. Gurung, P., T. A. Kucaba, S. P. Schoenberger, T. A. Ferguson, and T. S. Griffith. 2010. TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion. J. Leukoc. Biol. 88: 1217-1225.
54. Gurung, P., T. A. Kucaba, T. A. Ferguson, and T. S. Griffith. 2009. Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells. J. Immunol. 183: 6114-6123.
55. Unsinger, J., M. McGlynn, K. R. Kasten, A. S. Hoekzema, E. Watanabe, J. T. Muenzer, J. S. McDonough, J. Tschoep, T. A. Ferguson, J. E. McDunn, et al. 2010. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol. 184: 3768-3779.
56. Inoue, S., J. Unsinger, C. G. Davis, J. T. Muenzer, T. A. Ferguson, K. Chang, D. F. Osborne, A. T. Clark, C. M. Coopersmith, J. E. McDunn, and R. S. Hotchkiss. 2010. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J. Immunol. 184: 1401-1409.
57. Brahmamdam, P., S. Inoue, J. Unsinger, K. C. Chang, J. E. McDunn, and R. S. Hotchkiss. 2010. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J. Leukoc. Biol. 88: 233-240.
58. Husain, K. D., and C. M. Coopersmith. 2003. Role of intestinal epithelial apoptosis in survival. Curr. Opin. Crit. Care 9: 159-163. (Pubitemid 36408136)
59. Hotchkiss, R. S., K. W. Tinsley, and I. E. Karl. 2003. Role of apoptotic cell death in sepsis. Scand. J. Infect. Dis. 35: 585-592. (Pubitemid 37336877)